Back to Journals » OncoTargets and Therapy » Volume 9

Review

Profile of capecitabine/temozolomide combination in the treatment of well-differentiated neuroendocrine tumors

       
Total article views   HTML views PDF downloads Totals
16,815 Dovepress* 8,098+ 1,375 9,473
PubMed Central* 8,717 1,022 9,739
Totals 16,815 2,397 19,212
*Since 9 February 2016
+Since July 2016

View citations on PubMed and Google Scholar